Genelux (GNLX) Assets Average (2023 - 2026)
Genelux (GNLX) recorded quarterly Assets Average of $25.7 million in Q1 2026, up 16.78% quarter-over-quarter from $22.0 million in Q4 2025.
Genelux (GNLX) Assets Average (2023 - 2026) Analysis & Trends
Genelux's Assets Average history runs 4 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- In Q1 2026, Assets Average changed N/A year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at $25.7 million (changed N/A YoY), while the FY2025 annual figure was $26.9 million, down 14.16% from the prior year.
- Assets Average was $25.7 million for Q1 2026 at Genelux, up from $22.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $42.7 million in Q3 2024 to a low of $22.0 million in Q4 2025.
- Historically, Assets Average has averaged $31.1 million across 4 years, with a median of $29.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Assets Average advanced 21.01% in 2024, then plunged 41.3% in 2025.
- A 4-year view of Assets Average shows it stood at $31.0 million in 2023, then grew by 21.01% to $37.5 million in 2024, then slumped by 41.3% to $22.0 million in 2025, then increased by 16.78% to $25.7 million in 2026.
- The last three Assets Average figures came in at $25.7 million (Q1 2026), $22.0 million (Q4 2025), and $28.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 25.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.70 Mn |
| Dec 31, 2025 | 22.01 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Dec 31, 2024 | 37.49 Mn |
| Sep 30, 2024 | 42.72 Mn |
| Jun 30, 2024 | 34.93 Mn |
| Mar 31, 2024 | 26.28 Mn |
| Dec 31, 2023 | 30.98 Mn |